Z Edis, J Wang, MK Waqas, M Ijaz… - International journal of …, 2021 - Taylor & Francis
… Citation90 , Citation91 Bio conjugated QDs are also considered for the site-specific gene as well as drugdelivery in cancer. Targeting moieties, such as antibodies, Citation92 high-…
N Avramović, B Mandić, A Savić-Radojević, T Simić - Pharmaceutics, 2020 - mdpi.com
… DDSs with specific chemical functionalities that improve their hydrophilicity, drug loading and cellular interactions.Recentlydesigned multifunctional DDSs used in cancer therapy are …
… have focused on targeted therapy in the specificcancer site. Advances in nanotechnology, … discuss the anticancer drugdeliverysystems consisting of polymeric nanoparticles such as …
U Ruman, S Fakurazi, MJ Masarudin… - International journal of …, 2020 - Taylor & Francis
… , unwanted drugdistribution to the specific site of liver cancer … of nanocarrier-based drug deliverysystems for liver cancer … of individual nanocarrier in the drugdeliverysystem will also …
R Liu, C Luo, Z Pang, J Zhang, S Ruan, M Wu… - Chinese chemical …, 2023 - Elsevier
… -base medicine was approved for human cancertreatment, and the … of drugdelivery nanoparticles, we make critical illustrations about nanoparticles-based delivery of these specific …
Z Shi, Y Zhou, T Fan, Y Lin, H Zhang, L Mei - Smart Materials in Medicine, 2020 - Elsevier
… the therapeutic agents in tumor sites [3,4]. To fabricate such drugdeliverysystems, we need to comprehensively investigate the characteristics of the tumor, and properly select materials …
Y Dang, J Guan - Smart Materials in Medicine, 2020 - Elsevier
… Chitosan nanoparticles can target tumors on specific organs through passive targeting (also known as enhanced permeability and retention (EPR) effect [17]), active targeting, and …
M Alsehli - Saudi Pharmaceutical Journal, 2020 - Elsevier
… systems, drugrelease is controlled in response to specific … -responsive nanocarriers for drug delivery in cancer therapy. In … Over the last decade, various types of drugdeliverysystems …
… in the production of biosensors for diagnosis of genetic disorders or other molecular abnormalities, and also in drugdeliverysystems for a broad range of detection and therapeutic …